Thyroid News

Young adults who received radioactive iodine therapy for differentiated thyroid cancer were at 92% increased risk for leukemia and 23% increased risk for any solid malignancies vs. those who did not receive radioactive iodine therapy.

In an update on notable, recently conducted thyroid studies, a speaker reviewed the latest treatments and imaging modalities for children and adults that have the potential to change thyroidology practice.

Adults who underwent a thyroidectomy as first-line treatment for Graves’ disease had lower risks for all-cause mortality and cardiovascular disease than those treated with antithyroid drugs or radioactive iodine, according to study data.

Not everyone can agree on what to call thyroid eye disease. For some, it is thyroid-associated ophthalmopathy; for others, it is thyroid-related immune orbitopathy. It has also been referred to as Graves’ orbitopathy.

Traditionally, many experts in the field have advocated steroids. More recently, EUGOGO and others have advocated high-dose pulse steroid therapy in TED as that route of administration appears to be less associated with side effects.

Both exogenous hyperthyroidism and hypothyroidism are associated with increased odds for incident stroke, with risk increasing over time, according to findings published in the Journal of Clinical Endocrinology & Metabolism.

Exelixis announced that its cabozantinib tablet received FDA approval for patients aged 12 years and older who have previously treated radioactive iodine-refractory differentiated thyroid cancer.

The effect size for the correlation between hypothyroidism and clinical depression appeared significantly lower than previously thought, according to results of a systematic review and meta-analysis published in JAMA Psychiatry.

Combined levothyroxine and liothyronine therapy provides similar efficacy to levothyroxine monotherapy for adults with hypothyroidism, according to a systematic review and meta-analysis published in Thyroid.

Changes in thyrotropin-binding inhibitory immunoglobulin levels for people with refractory Graves’ disease differed for those undergoing total thyroidectomy vs. radioactive iodine therapy, according to study data.